THE ARISING · Longevity & Healthspan
Detailed Data Confirm Personalized mRNA Melanoma Vaccine Cut Recurrence Risk 42%
For people treated for melanoma, the hardest question is often whether the cancer will come back, and a vaccine built from each patient's own tumor has now shown it can lower that risk.
The Arising reported on this vaccine on October 22, when the focus was Moderna's stock. What is new is the detailed trial data, released at the ESMO cancer conference in Madrid. According to STAT's report of the study, the data confirm that the Moderna and Merck vaccine met its key endpoints in the melanoma trial.
This article is based on STAT's report. The study paper itself was not reviewed, and only the opening of STAT's article was available to us.
According to STAT, the personalized mRNA vaccine, called intismeran autogene, reduced the risk of disease recurrence by 42% compared with a standard treatment. STAT describes the trial as large and run by Moderna and Merck.
STAT reports that oncologists called the results an important advance for melanoma. The reason, according to the report, is that patients lived significantly longer without their cancer returning.
The vaccine works differently from a one-size-fits-all drug. According to STAT, it is an individualized therapy that targets the unique mutations, called neoantigens, found in a patient's own tumor. These are changes in the cancer's genes that set it apart from healthy cells. STAT says the approach relies on the same mRNA technology that allowed rapid development of Covid-19 vaccines.
For people at risk of recurrence, the practical meaning is that a treatment tailored to one person's tumor can delay the cancer's return better than the standard treatment it was compared with. That is the interpretation of the finding, not a promise about any individual's outcome.
STAT also reports that the success may usher in a new wave of treatments for other cancers. It adds that experts are debating how broadly the technology could apply. Whether it works beyond melanoma is not yet known.
The part of STAT's report available to us did not cover several questions that matter to patients. These include the full safety picture, whether the vaccine helps people live longer overall, and which patients benefit most. We cannot say what the trial found on those points.
What to watch next
The full study publication and the more detailed results, which should show how the benefit holds up over time, how safe the vaccine is, and whether it extends survival.
Two-Year Fish Oil Trial Finds No Memory or Brain-Shrinkage Benefit Detailed Data Confirm Personalized mRNA Melanoma Vaccine Cut Recurrence Risk 42% Blood Signatures of Fitness Linked to Lower Death Risk in UK Biobank Change in AI Face Age Between Photos Linked to Cancer Survival Untreated Sleep Apnea Linked to 69% Faster Cognitive Decline Over 10 Years Over 80 Nutrition Experts Urge White House to Release Ultra-Processed Food Definition Beetroot Juice and Postmenopausal Heart Oxygen Balance After Hard Exercise: A Small Trial Topical Urolithin A Lowered Eye Wrinkle Depth in Randomized Studies Short Breathing Exercises Blunted Heart Rate and Anxiety Under Stress Aerobic and Resistance Training Ended Up Equal for Type 2 Diabetes Plant and Dairy Protein Shakes Left Blood Chemistry Alike in Adults Over 50 Intensity Relative to Your Own Fitness Better Explained Fitness in Midlife Women Blood Flow Restriction Training Showed No Overall Advantage for Artery Health Cigarette Smoke Disrupts Eye Cell Mitochondria, Pointing to Macular Degeneration Risk Ultra-Processed Food Intake Leaves Distinct Blood Fat and Metabolite Signatures Gut-Made Kidney Toxins Linked to Tiny Brain Bleeds in Mice and Patients Flo App Survey of 17,494 Women Finds Gaps in Perimenopause Knowledge New Aging Framework Names Epigenetic Change the Dominant Driver of Aging Exercise Helps Blood Cancer Patients During Treatment, but Diet Evidence Lags Review: Protein Supplements Often Unnecessary Outside the Lab for Active Adults Ear Vagus Nerve Stimulation Linked to Less Inflammation After Surgery Fasting and Lean Mass Over 45: Short Trials, Small Differences Fragmented Sleep Tracked by Wrist Monitors Linked to More Brain Amyloid at Autopsy Blood Test for p-tau217 Predicted Decline Over 12 Years Steady Aerobic Exercise Raised Fitness on Average in Heart Disease Patients Rising Arterial Stiffness Linked to Progression of Heart-Kidney-Metabolic Disease Brain-Wide Gene Therapy Restored Memory in Alzheimer's and Old Mice Men With Heart and Metabolic Disease Show Faster Epigenetic Aging AI Spotted Heart Disease From Face and Tongue Photos in Small Test